[Full text] Armored Car T-Cells: T-Cell Cancer Immunotherapy | BTT – Dove Medical Press

IntroductionImmunotherapy Conventional cancer therapies like radiotherapy and chemotherapy are known to be effective at killing cancer cells, however they cannot effectively distinguish between malignant tissue and fast proliferating healthy cells, resulting in a variety of severe adverse effects.1,2 Due to the lack of specificity of available treatments, the idea for cancer immunotherapy emerged. One immunotherapy approach is cellular therapy which takes advantage of useful immune functions including antigen specificity, ability to expand on activation, trafficking to the area of interest and forming memory toward the target antigen.

Read more
Insights on the Gene Therapy Cell Culture Media Global Market to 2027 – Growth in Awareness Regarding Gene Therapy is Driving Growth – Yahoo Finance

DUBLIN, April 9, 2021 /PRNewswire/ -- The "Gene Therapy Cell Culture Media Market by Media Type, Viral Vectors Type and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo The global gene therapy cell culture media market accounted for $122.60 million in 2019, and is expected to reach $278.96 million by 2027, registering a CAGR of 10.6% from 2020 to 2027

Read more
Dynamic Stem Cell Therapy Announces The Launch of Its Advanced Stem Cell Treatment For Knee Injury – Press Release – Digital Journal

The team of experts at Dynamic Stem Cell Therapy has stated that they have what it takes to carry out a successful knee injury treatment, especially for athletes who want fast healing and recovery from injuries Dynamic Stem Cell Therapy, one of the most reputable stem cell treatment clinics in Nevada announces its innovative stem cell treatment to help people achieve fast recovery from injuries. They offer a state-of-the-art procedure that utilizes modern biotechnology to replace, renew, and repair damaged human tissue with incredible results. Stem cells are gaining popularity, especially among professional athletes

Read more
New stem cell therapy shows promise to prevent diabetes-related amputations – News-Medical.Net

According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients suffering from non-healing diabetic foot ulcers (DFU) with a cell preparation containing adult stem cells harvested from their own fat

Read more
Yumanity Therapeutics Announces Study Demonstrating In Vivo Efficacy of YTX-7739 in a Glioblastoma Multiforme (GBM) Mouse Model – StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. YTX-7739 demonstrates efficacy, including increased median overall survival, both as a single agent and in combination with temozolomide, the standard-of-care for GBM Shared therapeutic target with Parkinsons disease expands potential utility ofYTX-7739 to non-neurodegenerative diseases Study presented at SNO/NCI Joint Symposium: Targeting CNS Tumor Metabolism BOSTON, April 06, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a biopharmaceutical company focused on the development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced results of a study that demonstrate in vivo efficacy, including increased median overall survival, of YTX-7739 in a mouse model for glioblastoma multiforme (GBM)

Read more
Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy – News-Medical.Net

Children and young adults who receive CAR T-cell therapy for the most common childhood cancer - acute lymphoblastic leukemia - suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds. The research, with an average follow up of nearly five years, suggests that stem cell transplants offer long-term benefits for young patients who receive the cutting-edge immunotherapy. CAR T-cell therapy results in complete remission in 60%-100% of patients initially, but the relapse rate is high

Read more